Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

Skin irritation, in vivo: non-irritating, OECD TG 404, 2012

Eye irritation, in vivo: non-irritating, OECD TG 405, 2012

Key value for chemical safety assessment

Skin irritation / corrosion

Link to relevant study records

Referenceopen allclose all

Endpoint:
skin corrosion: in vitro / ex vivo
Data waiving:
other justification
Justification for data waiving:
an in vitro skin irritation study does not need to be conducted because adequate data from an in vivo skin irritation study are available
other:
Justification for type of information:
JUSTIFICATION FOR DATA WAIVING
In accordance with REACH Regulation (EC) No. 1907/2006 Annex VII, column 2 section 8.1.1 (as amended by Commission Regulation (EU) 2016/863) the in vitro skin corrosion (OECD TG 431) study does not need to be conducted based on the available information allowing a definitive conclusion on the classification of the substance. An available in vivo (OECD TG 404) skin irritation study is available and data in other endpoints (such as skin sensitisation and/or acute dermal toxicity) indicates that the substance is not skin corrosive and a definitive conclusion on the classification can be made. Furthermore, in accordance with section 1.2 of REACH Regulation (EC) No. 1907/2006 Annex XI the weight of evidence indicates that the substance is not skin corrosive and therefore in vitro testing may be omitted. According to ECHA Guidance on Information Requirements and Chemical Safety Assessment (Chapter R.7a: Endpoint Specific Guidance, R.7.2, July 2017) the study does not need to be conducted. Information as to the availability of the in vivo study is provided in 'attached justification'.
Endpoint:
skin irritation: in vivo
Type of information:
experimental study
Adequacy of study:
key study
Study period:
10-01-2012 to 20-01-2012
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: Guideline study performed under GLP. All relevant validity criteria were met.
Justification for type of information:
Information as to the availability of the in vivo study is provided in 'attached justification'.
Qualifier:
according to guideline
Guideline:
OECD Guideline 404 (Acute Dermal Irritation / Corrosion)
Deviations:
no
Qualifier:
according to guideline
Guideline:
EU Method B.4 (Acute Toxicity: Dermal Irritation / Corrosion)
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Remarks:
inspected: July 2011; signature: August 2011
Species:
rabbit
Strain:
New Zealand White
Remarks:
Hsdlf: NZW
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Recognised Supplier
- Age at study initiation: 12 to 20 weeks
- Weight at study initiation: 2.08 to 2.54 kg
- Housing: Individually housed in suspended cages.
- Diet (ad libitum): 2930 Teklad Global Certified Rabbit diet (Recognised Supplier); provided ad libitum
- Water (ad libitum): mains drinking water, ad libitum
- Acclimation period: at least 5 days

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 17 to 23
- Humidity (%): 30 to 70
- Air changes (per hr): at least 15
- Photoperiod (hrs dark / hrs light): 12 h light / 12 h dark

IN-LIFE DATES: From: 10-01-2012 To: 20-01-2012
Type of coverage:
semiocclusive
Preparation of test site:
clipped
Vehicle:
water
Controls:
no
Amount / concentration applied:
TEST MATERIAL
- Amount applied: 0.5g
- Concentration (if solution): 0.5g test material was moistened sufficiently with 0.5 mL distilled water.

VEHICLE
- Amount applied: 0.5 ml
Duration of treatment / exposure:
3 minutes, 1 hour and 4 hours - 1 male
4 hours - 2 males
Observation period:
72 hours (initial observation); additional observations are made daily up to Days 7 and 14 to assess the reversibility of skin reactions (as appropriate).
Number of animals:
3 males
Details on study design:
TEST SITE
- Area of exposure: dorsal
- Type of wrap if used: semi-occlusive (2.5 cm x 2.5 cm cotton gauze patch secured with surgical adhesive tape)

REMOVAL OF TEST SUBSTANCE
- Washing (if done): Yes, any residual test item removed by gentle swabbing with cotton wool soaked in distilled water.
- Time after start of exposure: 4 hours. Earlier if appropriate based on observations.

OBSERVATION TIME POINTS
(indicate if minutes, hours or days): 1 male: Immediately, 3 minutes, 1 hour, 4 hours, 24 hours, 48 hours and 72 hours. Additional observations daily up to 7 or 14 days, as appropriate ; 2 males: Immediately, 1 hour, 24 hours, 48 hours and 72 hours. Additional observations daily up to 7 or 14 days, as appropriate.

SCORING SYSTEM: Draize Scale:
Erythema and Eschar Formation
No erythema _______________________________________________________ 0
Very slight erythema (barely perceptible) __________________________________ 1
Well-defined erythema ________________________________________________ 2
Moderate to severe erythema ___________________________________________3
Severe erythema (beet redness) to slight eschar formation (injuries in depth) _______ 4

Oedema Formation
No oedema ________________________________________________________________ 0
Very slight oedema (barely perceptible) ___________________________________________ 1
Slight oedema (edges of area well-defined by definite raising) __________________________ 2
Moderate oedema (raised approximately 1 millimetre) _______________________________ 3
Severe oedema (raised more than 1 millimetre and extending beyond the area of exposure) ___4
Any other skin reactions and clinical signs of toxicity, if present, were also recorded.
Irritation parameter:
erythema score
Basis:
mean
Time point:
other: 24, 48 , 72 hours
Score:
0
Max. score:
4
Irritation parameter:
edema score
Basis:
mean
Time point:
other: 24, 48, 72 hours
Score:
0
Max. score:
4
Irritation parameter:
erythema score
Basis:
animal #1
Time point:
24/48/72 h
Score:
0
Max. score:
4
Remarks on result:
no indication of irritation
Irritation parameter:
edema score
Basis:
animal #1
Time point:
24/48/72 h
Score:
0
Max. score:
4
Remarks on result:
no indication of irritation
Irritation parameter:
erythema score
Basis:
animal #2
Time point:
24/48/72 h
Score:
0
Max. score:
4
Remarks on result:
no indication of irritation
Irritation parameter:
edema score
Basis:
animal #2
Time point:
24/48/72 h
Score:
0
Max. score:
4
Remarks on result:
no indication of irritation
Irritation parameter:
erythema score
Basis:
animal #3
Time point:
24/48/72 h
Score:
0
Max. score:
4
Remarks on result:
no indication of irritation
Irritation parameter:
other:
Basis:
animal #3
Time point:
24/48/72 h
Score:
0
Max. score:
4
Remarks on result:
no indication of irritation
Irritant / corrosive response data:
No evidence of skin irritation was noted (maximum score = 0 for erythema and edema) in n=3 males at all observation periods.
Other effects:
All males showed expected gain in body weight during the study.

Table 1. Individual Scores and Mean Scores following 4-hour exposure

Skin Reaction

Reading (hours)

1# Male

#2 Male

3# Male

Erythema/Escar Formation

24

0

0

0

 

48

0

0

0

 

72

0

0

0

 

Total

0.0

0.0

0.0

 

Mean

0.0

0.0

0.0

Oedema Formation

24

0

0

0

 

48

0

0

0

 

72

0

0

0

 

Total

0.0

0.0

0.0

 

Mean

0.0

0.0

0.0

 

Interpretation of results:
GHS criteria not met
Remarks:
Criteria used for interpretation of results: EU
Conclusions:
Under the conditions of this study, the test item is not considered to be irritating.
Executive summary:

The study was performed to OECD TG 404 and to assess the primary skin irritancy potential of the test substance in accordance with GLP in New Zealand White rabbits. The test item was applied sequentially. Initially, one male for 3-minute, 1-hour and 4-hour by semi-occluded application to the intact rabbit skin with 0.5 g test item moistened with 0.5 mL water introduced under a 2.5 cm x 2.5 cm cotton gauze patch on the clipped skin. The patch was secured in position with a strip of surgical adhesive tape. After exposure to the test substance, the patches were removed and individual dose sites were scored at approximately 1, 24, 48, and 72 hours. No effects were noted in one male between 3-minutes and 4-hour application and no effects were noted up to 72 hours observation. Subsequently, two further males were similarly treated by 4-hour introduction to the test item. The result was that no effects were noted following 4-hour application. A single 4-Hour, semi occluded application of the test item to the intact skin of three rabbits produced no erythema or oedema after patch removal in the observation period up to 72 hours . No corrosive effects were noted. Mean scores for following grading at 24, 48 and 72h were zero (score = 0) in erythema and eschar and in oedema scoring criteria. Under the conditions of the study, the test item is not considered to be a skin irritant.

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed (not irritating)

Eye irritation

Link to relevant study records

Referenceopen allclose all

Endpoint:
eye irritation: in vitro / ex vivo
Data waiving:
other justification
Justification for data waiving:
an in vitro eye irritation study does not need to be conducted because adequate data from an in vivo eye irritation study are available
other:
Justification for type of information:
JUSTIFICATION FOR DATA WAIVING
In accordance with REACH Regulation (EC) No. 1907/2006 Annex VII, column 2 section 8.1.2 (as amended by Commission Regulation (EU) 2016/863) the serious eye damage / eye irritation (OECD TG 437 or OECD TG 438) study does not need to be conducted based on the available information allowing a definitive conclusion on the classification of the substance. An available in vivo (OECD TG 405) eye irritation study is available that indicates that the substance is not eye irritating and a definitive conclusion on the classification can be made. According to ECHA Guidance on Information Requirements and Chemical Safety Assessment (Chapter R.7a: Endpoint Specific Guidance, R.7.2, July 2017) the study does not need to be conducted. Information as to the availability of the in vivo study is provided in 'attached justification'.
Endpoint:
eye irritation: in vivo
Type of information:
experimental study
Adequacy of study:
key study
Study period:
08-02-12 to 23-02-2012
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: Guideline study performed under GLP. All relevant validity criteria were met.
Justification for type of information:
Information as to the availability of the in vivo study is provided in 'attached justification'.
Qualifier:
according to guideline
Guideline:
OECD Guideline 405 (Acute Eye Irritation / Corrosion)
Deviations:
no
Qualifier:
according to guideline
Guideline:
EU Method B.5 (Acute Toxicity: Eye Irritation / Corrosion)
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Remarks:
inspected: July 2011; signature: August 2011
Species:
rabbit
Strain:
New Zealand White
Details on test animals or tissues and environmental conditions:
TEST ANIMALS
- Source: Recognised Supplier
- Age at study initiation: 12 to 20 weeks
- Weight at study initiation: 2.51 to 2.78 kg
- Housing: individually in suspended cages; with environmental enrichment
- Diet (ad libitum): 2930 Teklad Global Certified Rabbit diet (Recognised Supplier), ad libitum
- Water (ad libitum): mains drinking water, ad libitum
- Acclimation period: at least 5 days

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 17 to 23
- Humidity (%): 30 to 70
- Air changes (per hr): at least 15 changes per hour
- Photoperiod (hrs dark / hrs light): 12 hour light / 12 hour dark

IN-LIFE DATES: From: 8-02-2012 To: 23-02-2012
Vehicle:
unchanged (no vehicle)
Controls:
other: left eye remained untreated
Amount / concentration applied:
TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 0.1 mL ; which was determined to weigh approximately 91 mg (measured by gentle compacting into adapted syringe).
- Concentration (if solution): undiluted
Duration of treatment / exposure:
A volume of 0.1 mL of the test material, was placed into the conjunctival sac of the right eye, formed by gently pulling the lower lid away from the eyeball. The upper and lower eyelids were held together for about one second immediately after treatment, to prevent loss of the test material, and then released. The left eye remained untreated and was used for control purposes. Irrigation of the eye with distilled water or saline, after 1 hour was deemed not necessary during the study.
Observation period (in vivo):
Ocular assessment was conducted at approximately 1, 24, 48 and 72 hours after instillation of the test item, according to numerical evaluation.
Number of animals or in vitro replicates:
3 (male). Testing was conducted sequentially following testing with a sentinel.
Details on study design:
REMOVAL OF TEST SUBSTANCE
- Washing (if done): none

SCORING SYSTEM:
The irritation was assessed according to Draize (1977) numerical scoring system. At each observation period, the highest scores given were recorded. Any other ocular effects were also noted.

TOOL USED TO ASSESS SCORE: Examination of the eye was facilitated by the use of the light source from a standard ophthalmoscope.
Irritation parameter:
cornea opacity score
Basis:
mean
Time point:
24/48/72 h
Score:
0
Max. score:
4
Irritation parameter:
iris score
Basis:
mean
Time point:
24/48/72 h
Score:
0
Max. score:
2
Irritation parameter:
conjunctivae score
Basis:
mean
Time point:
24/48/72 h
Score:
0.4
Max. score:
3
Reversibility:
fully reversible within: 72 hours
Irritation parameter:
chemosis score
Basis:
mean
Time point:
24/48/72 h
Score:
0.3
Max. score:
4
Reversibility:
fully reversible within: 72 hours
Irritant / corrosive response data:
No corneal effects were noted, all scores were zero.
No iridial effects were noted, all scores were zero.
Moderate conjunctival irritation (score = 2) was noted in all treated eyes 1 h after treatment. Chemosis and Redness was minimal (score = 1) at the 24 h observation in all treated eyes and all effects had reversed (score = 0) at the 72 h observation.
Other effects:
All animals showed expected gain in bodyweight during the study.

Table 1.0: Individual and Mean Scores for Cornea, Iris and Conjunctivae

Number and Sex

Time After Treatment

Corneal Opacity

Iridial Inflammation

Conjunctival Redness

Conjunctival Chemosis

1# Male

24 Hours

0

0

1

1

48 Hours

0

0

1

0

72 Hours

0

0

0

0

Total

0

0

2

1

Mean

0.0

0.0

0.7

0.3

#2 Male

24 Hours

0

0

1

1

48 Hours

0

0

0

0

72 Hours

0

0

0

0

Total

0

0

1

1

Mean

0.0

0.0

0.3

0.3

#3 Male

24 Hours

0

0

1

1

48 Hours

0

0

0

0

72 Hours

0

0

0

0

Total

0

0

1

1

Mean

0.0

0.0

0.3

0.3

Interpretation of results:
GHS criteria not met
Remarks:
Criteria used for interpretation of results: EU
Conclusions:
Under the conditions of this study the test item is not irritating to the eye.
Executive summary:

The study was performed to OECD TG 405 and EU Method B.5  guidelines under GLP to assess the irritancy potential of the test material to the eye following a single application in the New Zealand White rabbit. A volume of 0.1 ml (weighing approximately 0.91 mg) of the test material was placed into the conjunctival sac of one eye of two animals. The other eye remained untreated and was used for control purposes. The test was conducted in a stepwise manner conducted singularly and then on a further two rabbits in accordance with the guideline. Assessment of ocular damage/irritation was made approximately 1 hour and 24, 48 and 72 hours following treatment. A single application of the test material to the non-irrigated eye of two rabbits produced no corneal opacity, iridial inflammation and moderate conjunctival irritation (redness and chemosis, score = 2) at one hour which was minimal (redness and chemosis, score = 1) after 24 hours. All treated eyes appeared normal at the 72-Hour observation (score = 0). Under the conditions of this study, the test item is not considered to be irritating to the eye.

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed (not irritating)

Respiratory irritation

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed (not irritating)

Additional information

Skin Irritation:

in vivo, OECD TG 404, 2012: The study was performed to OECD TG 404 and to assess the primary skin irritancy potential of the test substance in accordance with GLP in New Zealand White rabbits. The test item was applied sequentially. Initially, one male for 3-minute, 1-hour and 4-hour by semi-occluded application to the intact rabbit skin with 0.5 g test item moistened with 0.5 mL water introduced under a 2.5 cm x 2.5 cm cotton gauze patch on the clipped skin. The patch was secured in position with a strip of surgical adhesive tape. After exposure to the test substance, the patches were removed and individual dose sites were scored at approximately 1, 24, 48, and 72 hours. No effects were noted in one male between 3-minutes and 4-hour application and no effects were noted up to 72 hours observation. Subsequently, two further males were similarly treated by 4-hour introduction to the test item. The result was that no effects were noted following 4-hour application. A single 4-Hour, semi occluded application of the test item to the intact skin of three rabbits produced no erythema or oedema after patch removal in the observation period up to 72 hours . No corrosive effects were noted. Mean scores for following grading at 24, 48 and 72h were zero (score = 0) in erythema and eschar and in oedema scoring criteria. Under the conditions of the study, the test item is not considered to be a skin irritant.

 

Eye Irritation:

In vivo, OECD TG 405, 2012: The study was performed to OECD TG 405 and EU Method B.5 guidelines under GLP to assess the irritancy potential of the test material to the eye following a single application in the New Zealand White rabbit. A volume of 0.1 ml (weighing approximately 0.91 mg) of the test material was placed into the conjunctival sac of one eye of two animals. The other eye remained untreated and was used for control purposes. The test was conducted in a stepwise manner conducted singularly and then on a further two rabbits in accordance with the guideline. Assessment of ocular damage/irritation was made approximately 1 hour and 24, 48 and 72 hours following treatment. A single application of the test material to the non-irrigated eye of two rabbits produced no corneal opacity, iridial inflammation and moderate conjunctival irritation (redness and chemosis, score = 2) at one hour which was minimal (redness and chemosis, score = 1) after 24 hours. All treated eyes appeared normal at the 72-Hour observation (score = 0). Under the conditions of this study, the test item is not considered to be irritating to the eye.

 

Respiratory Irritation:

INHALATION: OECD TG 436, 2012 – The study was performed according to OECD TG 436 guideline in accordance with GLP to assess the acute inhalation toxicity of the test item. A single group of six Wistar (RccHan : WIST) strain rats (three males and three females) were exposed to an dust atmosphere of the test item. The groups were exposed for four hours using a nose only exposure system, followed by a fourteen day observation period. The mean maximum attainable atmosphere concentration was follows: 3.52 mg/L based on a nominal concentration of 74.6 mg/L. The characteristics of the achieved atmosphere where Mean Mass Median Diameter (particle size) and Inhalable Fraction < 4 μm were: 5.56 μm and 38.4% with geometric Standard Deviation 3.07. There was no male and female mortalities in the 3.52 mg/L maximum attainable atmosphere concentration. Common abnormalities noted during the study included increased respiratory rate, hunched posture, pilo-erection, red/brown staining around the eyes or snout and wet fur. All males and females recovered to appear normal from Days 3 to 5 post-exposure. All males and one female exhibited slight bodyweight losses on the first day post-exposure. Reasonable bodyweight development was noted for all males and females during the remainder of the recovery period with the exception of one female animal which exhibited a slight bodyweight loss from Days 1 to 3 post-exposure. All males and females gained weight during the study. Dark patches on the lungs were detected amongst one female and one male at necropsy. All other findings were normal. No mortality occurred and there was no indications of significant toxicity in a group of six rats exposed to a mean maximum attainable atmosphere concentration of 3.52 mg/L for four hours. Under the conditions of this study, the acute inhalation median lethal concentration 4 hr-LC50 was > 3.52 mg/L in the male/female RccHanTM : WIST strain rat. Under the conditions of this study, there were no indications of respiratory irritation.

 

Applicant assessment indicates: the MMAD was > 4 µm and GSD > 3.0 (actual MMAD = 5.56 µm and GSD = 3.07) at mean maximum achieved concentration 3.52 mg/L. It was considered that within this study: the test item could not achieve an atmosphere concentration of 2 mg/L or the equivalent particle size of 2.5 μm utilising grinding or using particle size selection devices within the exposure apparatus. It was considered by expert judgement as not possible to generate an appropriate test item atmosphere of MMAD 1 – 4 μm at 2 mg/L concentration. Reducing the test concentration resulted in an inability to achieve MMAD < 4 µm as was attempted and reported within the study. Using expert judgement, the achieved concentration would be applicable for classification and labelling on the basis the test item would be generally incapable of achieving higher human exposure during realistic usage conditions. Due to its physicochemical properties.

 

References:

1. OECD TG 436 (2009)

2. OECD 39 (2009)

 

Justification for selection of skin irritation / corrosion endpoint:

one in vivo GLP compliant Klimisch 1 study; within the in vivo study applicant evaluated and/or recalculated the mean and individual scoring in concluding the endpoint where necessary.

 

Justification for selection of eye irritation endpoint:

one in vivo GLP compliant Klimisch 1; within the in vivo study applicant evaluated and/or recalculated the mean and individual scoring in concluding the endpoint where necessary.

Justification for classification or non-classification

The substance does not meet classification criteria under Regulation (EC) No 1272/2008 for dermal irritation.

The substance does not meet classification criteria under Regulation (EC) No 1272/2008 for eye irritation.

 

For skin irritation, further in vitro skin corrosion testing does not need to be conducted based on the available information allowing a definitive conclusion on the classification of the substance. The substance does not demonstrate significant skin irritation potential necessary for classification and labelling within an available skin irritation in vivo assay (OECD TG 404).

 

For eye irritation, the weight of evidence indicates that the substance has the potential to cause transient mild irritating effects to the eye but which are insufficient for classification based on the mean scoring and evaluation of the results in three organisms demonstrating that the EU criteria had not been met. Effects in vivo on corneal opacity and iritis are low to non-existent and conjunctival effects are low which fully reversed within 72 hours; the overall evidence is indicative of transient and reversible effects on the eye.

References:

1. Guidance on Application of the CLP Criteria, ECHA, version 5.0, July 2017